An Open Letter to the Food and Drug Administration and Pharmaceutical Industry Concerning Drug Approval for Children With Inflammatory Bowel Disease
PMID: 39377256
Source: Inflamm Bowel Dis
DOI:
10.1093/ibd/izae226
Publication date:
2024-10-08
Year:
2024
Abstract
NULL